View More Recent Stories

Aug 27, 2024 02:30PM Ensysce Biosciences Announces IRB Approval for Key MPAR Study
Aug 27, 2024 08:10AM Ensysce Biosciences (ENSC) Receives $14 Million NIH Grant for Clinical Development of Novel Opioid with Overdose Protection
Aug 27, 2024 08:00AM Ensysce Biosciences Receives $14 Million NIH Grant for Clinical Development of Novel Opioid with Overdose Protection
Aug 15, 2024 04:30PM Ensysce Biosciences (ENSC) Misses Q1 EPS by 22c
Aug 14, 2024 04:15PM Ensysce Biosciences Reports Second Quarter 2024 Financial Results
Aug 7, 2024 12:00AM Ensysce Biosciences Provides Key Themes Following IASP 2024 Symposium
Jul 23, 2024 10:34AM Ensysce Biosciences (ENSC) Issues Mid-Year 2024 Update
Jul 23, 2024 08:00AM Ensysce Biosciences Provides Mid-Year 2024 Update
Jul 9, 2024 08:00AM Ensysce Biosciences Hosts IASP 2024 Symposium and Presents Clinical Dataset
Jun 27, 2024 08:00AM Ensysce Biosciences Discusses Key Themes from the EPHMRA 2024 Annual Meeting
Jun 25, 2024 08:05AM Ensysce Biosciences (ENSC) Announces Partnership to Scale and Manufacture New Drug Candidate
Jun 25, 2024 08:00AM Ensysce Biosciences Announces Partnership to Scale and Manufacture New Drug Candidate
Jun 25, 2024 08:00AM Ensysce Biosciences Announces Partnership to Scale and Manufacture New Drug Candidate
View More Recent Stories